Mucositis after Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study of Methotrexate- and Non-Methotrexate-Containing Graft-versus-Host Disease Prophylaxis Regimens
Open Access
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (5) , 383-388
- https://doi.org/10.1016/j.bbmt.2005.02.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantationTransplantation and Cellular Therapy, 2004
- Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositisCancer, 2004
- The pathobiology of mucositisNature Reviews Cancer, 2004
- Predictors of Oral Mucositis in Patients Receiving Hematopoietic Cell Transplants for Chronic Myelogenous LeukemiaJournal of Clinical Oncology, 2004
- Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationBlood, 2003
- Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatmentBone Marrow Transplantation, 2003
- Mucositis associated with stem cell transplantation: current status and innovative approaches to managementBone Marrow Transplantation, 2001
- Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2001
- Patient reports of complications of bone marrow transplantationSupportive Care in Cancer, 2000
- A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipientsCancer, 1993